245 related articles for article (PubMed ID: 33212160)
1. In Vitro and In Vivo Evaluation of 3D Printed Capsules with Pressure Triggered Release Mechanism for Oral Peptide Delivery.
Berg S; Krause J; Björkbom A; Walter K; Harun S; Granfeldt A; Janzén D; Nunes SF; Antonsson M; Van Zuydam N; Skrtic S; Hugerth A; Weitschies W; Davies N; Abrahamsson B; Bergström CAS
J Pharm Sci; 2021 Jan; 110(1):228-238. PubMed ID: 33212160
[TBL] [Abstract][Full Text] [Related]
2. Evaluation in pig of an intestinal administration device for oral peptide delivery.
Berg S; Uggla T; Antonsson M; Nunes SF; Englund M; Rosengren L; Fahraj M; Wu X; Govender R; Söderberg M; Janzén D; Van Zuydam N; Hugerth A; Larsson A; Abrahmsén-Alami S; Abrahamsson B; Davies N; Bergström CAS
J Control Release; 2023 Jan; 353():792-801. PubMed ID: 36493948
[TBL] [Abstract][Full Text] [Related]
3. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
4. A multi-mechanistic drug release approach in a bead dosage form and in vivo predictions.
Liu Y; Schwartz JB; Schnaare RL; Sugita ET
Pharm Dev Technol; 2003; 8(4):419-30. PubMed ID: 14601966
[TBL] [Abstract][Full Text] [Related]
5. The bioavailability of oral dosage forms of a new HIV-1 protease inhibitor, KNI-272, in beagle dogs.
Kiriyama A; Sugahara M; Yoshikawa Y; Kiso Y; Takada K
Biopharm Drug Dispos; 1996 Mar; 17(2):125-34. PubMed ID: 8907719
[TBL] [Abstract][Full Text] [Related]
6. 3D printed capsules for quantitative regional absorption studies in the GI tract.
Smith D; Kapoor Y; Hermans A; Nofsinger R; Kesisoglou F; Gustafson TP; Procopio A
Int J Pharm; 2018 Oct; 550(1-2):418-428. PubMed ID: 30172750
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs.
Hosny EA; Al-Shora HI; Elmazar MM
Int J Pharm; 2002 Apr; 237(1-2):71-6. PubMed ID: 11955805
[TBL] [Abstract][Full Text] [Related]
8. Effect of bioadhesive polymers, sodium salicylate, polyoxyethylene-9-lauryl ether, and method of preparation on the relative hypoglycemia produced by insulin enteric-coated capsules in diabetic beagle dogs.
Hosny EA; al-Shora HI; Elmazar MM
Drug Dev Ind Pharm; 2002 May; 28(5):563-70. PubMed ID: 12098845
[TBL] [Abstract][Full Text] [Related]
9. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate.
Raoof AA; Chiu P; Ramtoola Z; Cumming IK; Teng C; Weinbach SP; Hardee GE; Levin AA; Geary RS
J Pharm Sci; 2004 Jun; 93(6):1431-9. PubMed ID: 15124202
[TBL] [Abstract][Full Text] [Related]
10. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
[TBL] [Abstract][Full Text] [Related]
11. Improving the oral bioavailability of sulpiride by sodium oleate in rabbits.
Naasani I; Kohri N; Iseki K; Miyazaki K
J Pharm Pharmacol; 1995 Jun; 47(6):469-73. PubMed ID: 7674129
[TBL] [Abstract][Full Text] [Related]
12. Enteric-coated insulin capsules: a combination with or a replacement of oral hypoglycaemic drugs.
Hosny EA; el-Bagory IM; al-Jenoobi FI
Boll Chim Farm; 2002; 141(5):379-84. PubMed ID: 12481381
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation.
Simoni P; Cerrè C; Cipolla A; Polimeni C; Pistillo A; Ceschel G; Roda E; Roda A
Pharmacol Res; 1995 Feb; 31(2):115-9. PubMed ID: 7596954
[TBL] [Abstract][Full Text] [Related]
14. New Perspective Enteric-Coated Tablet Dosage Form for Oral Administration of Ceftriaxone: In Vitro and In Vivo Assessments.
Maghrabia AE; Boughdady MF; Meshali MM
AAPS PharmSciTech; 2019 Sep; 20(7):306. PubMed ID: 31512022
[TBL] [Abstract][Full Text] [Related]
15. Enteric-coated tablet of risedronate sodium in combination with phytic acid, a natural chelating agent, for improved oral bioavailability.
Kim JS; Jang SW; Son M; Kim BM; Kang MJ
Eur J Pharm Sci; 2016 Jan; 82():45-51. PubMed ID: 26594027
[TBL] [Abstract][Full Text] [Related]
16. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
[TBL] [Abstract][Full Text] [Related]
17. The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.
Cohen AF; Kroon R; Schoemaker HC; Breimer DD; Van Vliet-Verbeek A; Brandenburg HC
Br J Clin Pharmacol; 1993 Feb; 35(2):136-42. PubMed ID: 8443031
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs.
Rama Prasad YV; Eaimtrakarn S; Ishida M; Kusawake Y; Tawa R; Yoshikawa Y; Shibata N; Takada K
Int J Pharm; 2003 Dec; 268(1-2):13-21. PubMed ID: 14643972
[TBL] [Abstract][Full Text] [Related]
19. Effect of bio-adhesive polymers, sodium salicylate, polyoxyethylene-9-lauryl ether and method of preparation on the relative hypoglycemia produced by insulin enteric coated capsules in diabetic beagle dogs.
Hosny EA; al-Shora HI; el-mazar MM
Boll Chim Farm; 2002; 141(1):67-74. PubMed ID: 12064061
[TBL] [Abstract][Full Text] [Related]
20. 3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen.
Gaurkhede SG; Osipitan OO; Dromgoole G; Spencer SA; Pasqua AJD; Deng J
J Pharm Sci; 2021 Dec; 110(12):3829-3837. PubMed ID: 34469748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
